ABL Awarded NIH Contract for Continued Support of HIV Vaccine Development
yahoo.com
finance
2022-10-20 18:41:00

ROCKVILLE, Md., Oct. 20, 2022 /PRNewswire/ -- Advanced BioScience Laboratories (ABL), a global Contract Development and Manufacturing Organization (CDMO) for biotherapies, oncolytics and viral vector vaccines, announced it has been awarded a contract for "Preclinical and translational vaccine development for HIV and other candidate agents" by the Division of AIDS (DAIDS) within the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH).

According to the WHO, there are over 38 million individuals living with HIV worldwide.
